,,ii #aadth ,,congress #b;d ,session ,s4 #bgdb ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,april #d1 #bjaf ,mr4 ,alexander 7for himself1 ,mrs4 ,murray1 ,mr4 ,kirk1 and ,ms4 ,warren7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to amend title ,,iv of the ,public ,health ,service ,act regarding the national research institutes1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,promoting ,biomedical ,research and ,public ,health for ,patients ,act4 #b4 ,triennial reports of ,director of ,,nih ,section #djc of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhc7 is amended-- 7#a7 in the heading1 by striking ,biennial and inserting ,triennial2 and 7#b7 in subsection 7a7-- 7,a7 in the matter preceding paragraph 7#a71 by striking biennial and inserting triennial2 7,b7 by amending paragraph 7#c7 to read as follows3 7#c7 ,a description of intra-,,nih activities1 including identification of the percentage of funds made available by each national research institute and national center with respect to each applicable fiscal year for conducting or supporting research that involves collaboration between the institute or center and #a or more other national research institutes or national centers and recommendations for promoting coordination of information among the centers of excellence4 2 7,c7 in paragraph 7#d7-- 7i7 in subparagraph 7,b71 by striking demographic variables and other variables and inserting demographic variables1 including biological and social variables and relevant age categories1 and determinants of health2 and 7ii7 in subparagraph 7,c77v7-- 7,i7 by striking demographic variables and such and inserting demographic variables1 including relevant age categories1 information submitted by each national research institute and national center to the ,director of ,,nih under section #dib;,b7f71 and such2 and 7,,ii7 by striking 7regarding inclusion of women and minorities in clinical research7 and inserting and other applicable requirements regarding inclusion of demographic groups2 and 7,d7 in paragraph 7#f7-- 7i7 in the matter preceding subparagraph 7,a71 by striking the following3 and inserting the following--2 7ii7 in subparagraph 7,a7-- 7,i7 by striking ,an evaluation and inserting an evaluation2 and 7,,ii7 by striking the period and inserting 2 and2 7iii7 by striking subparagraphs 7,b7 and 7,d72 7iv7 by redesignating subparagraph 7,c7 as subparagraph 7,b72 and 7v7 in subparagraph 7,b71 as redesignated by clause 7iv71 by striking ,recommendations and inserting recommendations4 #c4 ,administrative burden on investigators 7a7 ,disclosure of financial conflicts of interest 7#a7 ,in general ,not later than #b years after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary7 shall-- 7,a7 lead a review by research funding agencies of all regulations and policies related to the disclosure of financial conflicts of interest1 including the minimum threshold for reporting financial conflicts of interest2 and 7,b7 make revisions1 as appropriate1 to harmonize existing policies and reduce administrative burden on researchers while maintaining the integrity and credibility of research findings and protections of human participants4 7#b7 ,considerations ,in updating policies under paragraph 7#a77;,b71 the ,secretary shall consider-- 7,a7 modifying the timelines for the reporting of financial conflicts of interest to just in time information by institutions receiving grant or cooperative agreement funding from the ,national ,institutes of ,health2 7,b7 ensuring that financial interest disclosure reporting requirements are appropriate for1 and relevant to1 awards that will directly fund research1 which may include modification of the definition of the term investigator2 and 7,c7 updating any applicable training modules of the ,national ,institutes of ,health related to ,federal financial interest disclosure4 7b7 ,monitoring of subrecipients of funding from the ,national ,institutes of ,health ,the ,director of the ,national ,institutes of ,health shall implement measures to reduce the administrative burdens related to monitoring of subrecipients of grants by primary awardees of funding from the ,national ,institutes of ,health1 which may incorporate findings and recommendations from existing and ongoing activities4 ,such measures may include1 as appropriate-- 7#a7 an exemption from subrecipient monitoring requirements1 upon request from the primary awardees1 provided that-- 7,a7 the subrecipient is subject to ,federal audit requirements pursuant to the ,uniform ,guidance of the ,office of ,management and ,budget2 7,b7 the primary awardee conducts a formal or informal evaluation of each subrecipient's risk of noncompliance with ,federal statutes and regulations1 and the conditions of the subaward2 and 7,c7 such exemption does not absolve the primary awardee of liability for misconduct by subrecipients2 and 7#b7 the implementation of alternative grant structures that obviate the need for subrecipient monitoring1 which may include collaborative grant models allowing for multiple primary awardees4 7c7 ,reporting of financial expenditures ,the ,secretary1 in consultation with the ,director of the ,national ,institutes of ,health1 shall evaluate financial expenditure reporting procedures and requirements for recipients of funding from the ,national ,institutes of ,health and take action1 as appropriate1 to avoid duplication between department and agency procedures and requirements and minimize burden to funding recipients4 7d7 ,animal care and use in research ,not later than #b years after the date of enactment of this ,act1 the ,director of the ,national ,institutes of ,health1 in collaboration with the ,secretary of ,agriculture and the ,commissioner of ,food and ,drugs1 shall complete a review of applicable regulations and policies for the care and use of laboratory animals and make revisions1 as appropriate1 to reduce administrative burden on investigators while maintaining the integrity and credibility of research findings and protection of research animals4 ,in carrying out this effort1 the ,director shall seek the input of experts1 as appropriate4 ,the ,director shall-- 7#a7 identify ways to ensure such regulations and policies are not inconsistent1 overlapping1 or unnecessarily duplicative1 including with respect to inspection and review requirements by ,federal agencies and accrediting associations2 7#b7 take steps to eliminate or reduce identified inconsistencies1 overlap1 or duplication among such regulations and policies2 and 7#c7 take other actions1 as appropriate1 to improve the coordination of regulations and policies with respect to research with laboratory animals4 7e7 ,documentation of personnel expenses ,the ,secretary shall clarify the applicability of the requirements under the ,office of ,management and ,budget ,uniform ,guidance for management and certification systems adopted by entities receiving ,federal research grants through the ,department of ,health and ,human ,services regarding documentation of personnel expenses1 including clarification of the extent to which any flexibility to such requirements specified in such ,uniform ,guidance applies to entities receiving grants through the ,department of ,health and ,human ,services4 7f7 ,research policy board 7#a7 ,establishment ,not later than #a year after the date of enactment of this ,act1 the ,director of the ,office of ,management and ,budget shall establish an advisory committee1 to be known as the ,research ,policy ,board 7referred to in this subsection as the ,board71 to provide the ,director and other members of the ,federal ,government with information on the effects of regulations related to ,federal research requirements4 7#b7 ,membership 7,a7 ,in general ,the ,board shall include not more than #aj ,federal members1 including each of the following ,federal members or their designees3 7i7 ,the ,administrator of the ,office of ,information and ,regulatory ,affairs of the ,office of ,management and ,budget4 7ii7 ,the ,director of the ,office of ,science and ,technology ,policy4 7iii7 ,the ,secretary of ,health and ,human ,services4 7iv7 ,the ,director of the ,national ,science ,foundation4 7v7 ,the secretaries and directors of other departments and agencies that support or regulate scientific research1 as determined by the ,director of the ,office of ,management and ,budget4 7,b7 ,non-,federal members ,the ,board shall be comprised of not less than #i and not more than #ab representatives of academic research institutions1 other private1 nonprofit research institutions1 or other nonprofit organizations with relevant expertise4 ,such members shall be appointed by a formal process1 to be established by the ,director of the ,office of ,management and ,budget1 in consultation with the ,federal membership1 and that incorporates-- 7i7 nomination by members of the nonprofit scientific research community1 including academic research institutions2 and 7ii7 procedures to fill membership positions vacated before the end of a member's term4 7#c7 ,purpose and responsibilities ,the ,board shall make recommendations regarding the modification and harmonization of regulations and policies having similar purposes across research funding agencies to ensure that the administrative burden of such research policy and regulation is minimized to the greatest extent possible and consistent with maintaining responsible oversight of federally funded research4 ,activities of the ,board may include-- 7,a7 providing thorough and informed analysis of regulations and policies2 7,b7 identifying negative or adverse consequences of existing policies and making actionable recommendations regarding possible improvement of such policies2 7,c7 making recommendations with respect to efforts within the ,federal ,government to improve coordination of regulation and policy related to research2 7,d7 creating a forum for the discussion of research policy or regulatory gaps1 challenges1 clarification1 or harmonization of such policies or regulation1 and best practices2 and 7,e7 conducting ongoing assessment and evaluation of regulatory burden1 including development of metrics1 periodic measurement1 and identification of process improvements and policy changes4 7#d7 ,expert subcommittees ,the ,board may form temporary expert subcommittees1 as appropriate1 to develop timely analysis on pressing issues and assist the ,board in anticipating future regulatory challenges1 including those emerging from new scientific advances4 7#e7 ,reporting requirements ,not later than #b years after the date of enactment of this ,act1 and once thereafter1 the ,board shall submit a report to the ,director of the ,office of ,management and ,budget1 the ,administrator of the ,office of ,information and ,regulatory ,affairs of the ,office of ,management and ,budget1 the ,director of the ,office of ,science and ,technology ,policy1 the heads of relevant ,federal departments and agencies1 the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate1 and the ,committee on ,energy and ,commerce of the ,house of ,representatives containing formal recommendations on the conceptualization1 development1 harmonization1 and reconsideration of scientific research policy1 including the regulatory benefits and burdens4 7#f7 ,sunset ,the ,board shall terminate on ,september #cj1 #bjbj4 7#g7 ,,gao report ,not later than #d years after the date of enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall conduct an independent evaluation of the activities carried out by the ,board pursuant to this subsection and submit to the appropriate committees of ,congress a report regarding the results of the independent evaluation4 ,such report shall review and assess the ,board's activities with respect to the responsibilities described in paragraph 7#c74 #d4 ,reimbursement for research substances and living organisms ,section #cja of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bda7 is amended-- 7#a7 in the flush matter at the end of subsection 7a7-- 7,a7 by redesignating such matter as subsection 7f77#a72 and 7,b7 by moving such matter so as to appear at the end of such section2 and 7#b7 in subsection 7f7 7as so redesignated71 by adding at the end the following3 7#b7 ,where research substances and living organisms are made available under paragraph 7#a7 through contractors1 the ,secretary may direct such contractors to collect payments on behalf of the ,secretary for the costs incurred to make available such substances and organisms and to forward amounts so collected to the ,secretary1 in the time and manner specified by the ,secretary4 7#c7 ,amounts collected under paragraph 7#b7 shall be credited to the appropriations accounts that incurred the costs to make available the research substances and living organisms involved1 and shall remain available until expended for carrying out activities under such accounts4 4 #e4 ,streamlining ,,nih reporting requirements 7a7 ,trans-,,nih research reporting ,section #djb;,a7c77#b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhb;a7c77#b77 is amended-- 7#a7 by amending subparagraph 7,b7 to read as follows3 7,b7 ,reporting ,not later than #b years after the date of enactment of ,promoting ,biomedical ,research and ,public ,health for ,patients ,act1 the head of each national research institute or national center shall submit to the ,director of ,,nih a report1 to be included in the triennial report under section #djc1 on the amount made available by the institute or center for conducting or supporting research that involves collaboration between the institute or center and #a or more other national research institutes or national centers4 2 and 7#b7 in subparagraphs 7,d7 and 7,e7 by striking 7,b77i7 each place it appears and inserting 7,b74 7b7 ,fraud and abuse reporting ,section #djc;,b of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhc;a-#a7 is amended-- 7#a7 by striking subsection 7b72 7#b7 by redesignating subsection 7c7 as subsection 7b72 and 7#c7 in subsection 7b7 7as so redesignated71 by striking subsections 7a7 and 7b7 and inserting subsection 7a74 7c7 ,doctoral degrees reporting ,section #djc;,c7a77#b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhc;a-#b7;a77#b77 is amended by striking 7not including any leaves of absence74 7d7 ,vaccine reporting ,section #djd;,b of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhc;d7 is amended-- 7#a7 by striking subsection 7b72 and 7#b7 by striking 7a7 ,development of ,new ,vaccines4--,the ,secretary and inserting ,the ,secretary4 7e7 ,national ,center for ,advancing ,translational ,sciences ,section #dgi7;c7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhg7;c77 is amended-- 7#a7 in the subsection heading1 by striking ,annual and inserting ,biennial2 and 7#b7 in the matter preceding paragraph 7#a71 by striking an annual report and inserting a report on a biennial basis4 7f7 ,review of centers of excellence 7#a7 ,repeal ,section #djd;,h of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhc;j7 is repealed4 7#b7 ,conforming amendment ,section #cii;,,ee7c7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhj;i-#d7;c77 is amended by striking #cii;,,cc1 #djd;,h1 and inserting #cii;,,cc4 7g7 ,rapid ,,hiv test report ,section #ejb7;a7 of the ,ryan ,white ,,care ,act ,amendments of #bjjj 7#db ,u4,s4,c4 #cjj;cc note7 is amended-- 7#a7 by striking paragraph 7#b72 and 7#b7 by redesignating paragraph 7#c7 as paragraph 7#b74 7h7 ,biennial report 7#a7 ,repeal ,section #dfd,y of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bheq-#c7 is repealed4 7#b7 ,conforming amendment ,section #dfd,x7g7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bheq-#b7;g77 is amended by striking biennial report made under section #dfd,y1 and inserting triennial report made under section #djc4 #f4 ,national ,vaccine ,injury ,compensation ,program 7a7 ,additional vaccines ,section #baad7;e7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#ad7;e77 is amended by adding at the end the following3 7#c7 ,vaccines recommended for use in pregnant women ,the ,secretary shall revise the ,vaccine ,injury ,table included in subsection 7a71 through the process described in subsection 7c71 to include vaccines recommended by the ,centers for ,disease ,control and ,prevention for routine administration in pregnant women and the information described in subparagraphs 7,b7 and 7,c7 of paragraph 7#b7 with respect to such vaccines4 4 7b7 ,petition content ,section #baaa of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#aa7 is amended by adding at the end the following3 7f7 ,maternal immunization 7#a7 ,in general ,notwithstanding any other provision of law1 for purposes of this subtitle1 both a woman who received a covered vaccine while pregnant and any child who was in utero at the time such woman received the vaccine shall be considered persons to whom the covered vaccine was administered and persons who received the covered vaccine4 7#b7 ,definition ,as used in this subsection1 the term child shall have the meaning given that term by subsections 7a7 and 7b7 of section #h of title #a1 ,united ,states ,code1 except that1 for purposes of this subsection1 such section #h shall be applied as if the term include in subsection 7a7 of such section were replaced with the term mean4 4 7c7 ,petitioners ,section #baaa7;b77#b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;aa-#aa7;b77#b77 is amended by adding ,a covered vaccine administered to a pregnant woman shall constitute more than one administration1 one to the mother and one to each child 7as such term is defined in subsection 7f77#b77 who was in utero at the time such woman was administered the vaccine4 at the end4 #g4 ,vaccine meetings2 report on vaccine innovation 7a7 ,vaccine meetings ,the ,director of the ,centers for ,disease ,control and ,prevention shall ensure that appropriate staff within the relevant centers and divisions of the ,office of ,infectious ,diseases1 and others1 as appropriate1 coordinate with respect to the public health needs1 epidemiology1 and program planning and implementation considerations related to immunization1 including with regard to meetings with stakeholders related to such topics4 7b7 ,report on vaccine innovation 7#a7 ,in general ,not later than #a year after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary71 in collaboration with appropriate agencies or offices within the ,department of ,health and ,human ,services1 including the ,national ,institute of ,allergy and ,infectious ,diseases and the ,biomedical ,advanced ,research and ,development ,authority1 shall issue to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives1 and post publicly on the ,internet website of the ,department of ,health and ,human ,services1 a report on ways to promote innovation in the development of vaccines that minimize the burden of infectious disease4 7#b7 ,contents ,the report described in paragraph 7#a7 shall review the current status of vaccine development and1 as appropriate-- 7,a7 consider the optimal process to determine which vaccines would be beneficial and how information on such vaccines is disseminated to key stakeholders2 7,b7 examine and identify whether obstacles exist that inhibit the development of beneficial vaccines2 and 7,c7 make recommendations about how best to remove any obstacles identified under subparagraph 7,b7 in order to promote and incentivize vaccine innovation and development4 7#c7 ,consultation ,in preparing the report under subsection 7a71 the ,secretary may consult with-- 7,a7 representatives of relevant ,federal agencies and departments1 including the ,department of ,defense and the ,department of ,veterans ,affairs2 7,b7 academic researchers2 7,c7 developers and manufacturers of vaccines2 7,d7 medical and public health practitioners2 7,e7 representatives of patient1 policy1 and advocacy organizations2 and 7,f7 representatives of other entities1 as the ,secretary determines appropriate4 #h4 ,technical updates to clinical trials database ,section #djb7;j77#b77;,d7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhb7;j77#b77;,d77 is amended-- 7#a7 in clause 7ii77,i71 by inserting before the semicolon 1 unless the responsible party affirmatively requests that the ,director of ,,nih publicly post such clinical trial information for an applicable device clinical trial prior to such date of clearance or approval2 and 7#b7 by adding at the end the following3 7iii7 ,option to make certain clinical trial information available earlier ,the ,director of ,,nih shall inform responsible parties of the option to request that clinical trial information for an applicable device clinical trial be publicly posted prior to the date of clearance or approval1 in accordance with clause 7ii77,i74 7iv7 ,combination products ,an applicable clinical trial for a product that is a combination of drug1 device1 or biological product shall be considered-- 7,i7 an applicable drug clinical trial1 if the ,secretary determines under section #ejc7;g7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act that the primary mode of action of such product is that of a drug or biological product2 or 7,,ii7 an applicable device clinical trial1 if the ,secretary determines under such section that the primary mode of action of such product is that of a device4 4 #i4 ,compliance activities reports 7a7 ,definitions ,in this section3 7#a7 ,applicable clinical trial ,the term applicable clinical trial has the meaning given the term in section #djb7;j7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhb7;j774 7#b7 ,director of ,,nih ,the term ,director of ,,nih means the ,director of the ,national ,institutes of ,health4 7#c7 ,secretary ,the term ,secretary means the ,secretary of ,health and ,human ,services4 7b7 ,report on activities ,to encourage compliance ,not later than #b years after the date of enactment of this ,act1 the ,secretary1 acting through the ,director of ,,nih and in collaboration with the ,commissioner of ,food and ,drugs1 shall submit to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives1 a report that describes education and outreach1 guidance1 enforcement1 and other activities undertaken to encourage compliance with section #djb7;j7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhb7;j774 7c7 ,reports on clinical trials 7#a7 ,in general ,not later than #b years after the final compliance date under the final rule implementing section #djb7;j7 of the ,public ,health ,service ,act1 and every #b years thereafter for the next #d years1 the ,secretary1 acting through the ,director of ,,nih and in collaboration with the ,commissioner of ,food and ,drugs1 shall submit to the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives1 a report describing-- 7,a7 the total number of applicable clinical trials with complete data bank registration information registered during the period for which the report is being prepared 7broken down by each year of such reporting period72 7,b7 the total number of applicable clinical trials registered during the period for which the report is being prepared for which results have been submitted to the data bank 7broken down by each year of such reporting period72 7,c7 the activities undertaken by the ,secretary during the period for which the report is being prepared to educate responsible persons about data bank registration and results submission requirements1 including through issuance of guidance documents1 informational meetings1 and training sessions2 and 7,d7 the activities described in the report submitted under subsection 7b74 7#b7 ,actions to enforce compliance ,after the ,secretary has undertaken the educational activities described in paragraph 7#a77;,c71 the ,secretary shall include in subsequent reports submitted under paragraph 7#a7 the number of actions taken by the ,secretary during the period for which the report is being prepared to enforce compliance with data bank registration and results submission requirements4 #aj4 ,appointment of directors of national research institutes and national centers ,subsection 7a7 of section #dje of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhd7 is amended as follows3 7a7 ,appointment 7#a7 ,in general ,the ,director of the ,national ,cancer ,institute shall be appointed by the ,president and the ,directors of the other national research institutes and centers shall be appointed by the ,secretary1 acting through the ,director of ,,nih4 ,each ,director of a national research institute or national center shall report directly to the ,director of ,,nih4 7#b7 ,appointment 7,a7 ,term ,a ,director of a national research institute or national center who is appointed by the ,secretary1 acting through the ,director of ,,nih1 shall be appointed for #e years4 7,b7 ,reappointment ,at the end of the term of a ,director of a national research institute or national center1 the ,director may be reappointed4 ,there shall be no limit on the number of terms that a ,director may serve4 7,c7 ,vacancies ,if the office of a ,director of a national research institute or national center becomes vacant before the end of such ,director's term1 the ,director appointed to fill the vacancy shall be appointed for a #e-year term starting on the date of such appointment4 7,d7 ,current directors ,each ,director of a national research institute or national center who is serving on the date of enactment of the ,promoting ,biomedical ,research and ,public ,health for ,patients ,act shall be deemed to be appointed for a #e-year term under this subsection beginning on such date of enactment4 7,e7 ,rule of construction ,nothing in this subsection shall be construed to limit the ability of the ,director of ,,nih or a ,director of a national research institute or center to terminate the appointment of such ,director of a national research institute or center prior to the expiration of such ,director's #e-year term4 7#c7 ,nonapplication of certain provision ,the restrictions contained in section #bjb of the ,departments of ,labor1 ,health and ,human ,services1 and ,education1 and ,related ,agencies ,appropriations ,act1 #aiic 7,public ,law #ajb-cid2 #db ,u4,s4,c4 #bch;f note7 related to consultants and individual scientists appointed for limited periods of time shall not apply to ,directors appointed under this subsection4 4 #aa4 ,national ,center for ,advancing ,translational ,sciences ,section #dgi7;b7 of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhg7;b77 is amended-- 7#a7 in paragraph 7#a71 by striking phase ,,iia and inserting phase ,,iib2 and 7#b7 in paragraph 7#b7-- 7,a7 in the matter preceding subparagraph 7,a71 by striking phase ,,iib and inserting phase ,,iii2 7,b7 in subparagraph 7,a71 by striking phase ,,iib and inserting phase ,,iii2 7,c7 in subparagraph 7,b71 by striking phase ,,iia and inserting phase ,,iib2 and 7,d7 in subparagraph 7,c71 by striking phase ,,iib and inserting phase ,,iii4